Jane Street Group LLC lessened its stake in shares of Proto Labs, Inc. (NYSE:PRLB - Free Report) by 40.6% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 57,955 shares of the industrial products company's stock after selling 39,668 shares during the period. Jane Street Group LLC owned about 0.24% of Proto Labs worth $2,265,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds have also bought and sold shares of the company. Dimensional Fund Advisors LP increased its position in Proto Labs by 5.5% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,300,864 shares of the industrial products company's stock worth $50,851,000 after buying an additional 68,006 shares during the last quarter. First Trust Advisors LP grew its position in shares of Proto Labs by 71.9% in the fourth quarter. First Trust Advisors LP now owns 738,576 shares of the industrial products company's stock valued at $28,871,000 after purchasing an additional 308,970 shares during the last quarter. Renaissance Technologies LLC grew its position in shares of Proto Labs by 2.7% in the fourth quarter. Renaissance Technologies LLC now owns 571,851 shares of the industrial products company's stock valued at $22,354,000 after purchasing an additional 15,000 shares during the last quarter. S Squared Technology LLC grew its position in shares of Proto Labs by 5.1% in the fourth quarter. S Squared Technology LLC now owns 307,003 shares of the industrial products company's stock valued at $12,001,000 after purchasing an additional 15,000 shares during the last quarter. Finally, Northern Trust Corp grew its position in shares of Proto Labs by 3.4% in the fourth quarter. Northern Trust Corp now owns 281,639 shares of the industrial products company's stock valued at $11,009,000 after purchasing an additional 9,314 shares during the last quarter. Institutional investors own 84.54% of the company's stock.
Proto Labs Stock Performance
Shares of PRLB stock traded down $0.07 during trading on Monday, hitting $41.01. The company had a trading volume of 136,460 shares, compared to its average volume of 234,933. The firm has a market capitalization of $974.85 million, a P/E ratio of 63.09 and a beta of 1.37. The stock's 50-day moving average price is $36.02 and its 200 day moving average price is $38.82. Proto Labs, Inc. has a one year low of $25.76 and a one year high of $46.73.
Proto Labs (NYSE:PRLB - Get Free Report) last issued its quarterly earnings results on Friday, May 2nd. The industrial products company reported $0.33 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.29 by $0.04. The business had revenue of $126.21 million during the quarter, compared to analysts' expectations of $123.71 million. Proto Labs had a return on equity of 2.44% and a net margin of 3.31%. The firm's revenue for the quarter was down 1.3% compared to the same quarter last year. During the same period in the previous year, the company posted $0.40 earnings per share. On average, research analysts anticipate that Proto Labs, Inc. will post 0.81 earnings per share for the current fiscal year.
Proto Labs announced that its Board of Directors has initiated a stock repurchase plan on Friday, February 7th that authorizes the company to repurchase $100.00 million in shares. This repurchase authorization authorizes the industrial products company to purchase up to 9.8% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company's management believes its stock is undervalued.
Analyst Upgrades and Downgrades
PRLB has been the topic of several research reports. Needham & Company LLC reaffirmed a "hold" rating on shares of Proto Labs in a research report on Friday, February 7th. Cantor Fitzgerald upped their target price on Proto Labs from $40.00 to $50.00 and gave the company an "overweight" rating in a research report on Monday, February 10th. Finally, StockNews.com raised Proto Labs from a "buy" rating to a "strong-buy" rating in a research report on Tuesday, May 6th. Two research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $43.67.
View Our Latest Stock Report on PRLB
About Proto Labs
(
Free Report)
Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.
Featured Stories
Before you consider Proto Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Proto Labs wasn't on the list.
While Proto Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
